Brown-Forman Corporation
BF-B
$26.17
+3.77%
Brown-Forman Corporation is a leading global producer and marketer of premium alcoholic beverages, operating in the Wineries & Distilleries industry. The company is distinguished as a dominant player with a powerful portfolio of iconic brands, most notably the global whiskey giant Jack Daniel's, alongside other key labels like Old Forester, Herradura, and Finlandia. The current investor narrative centers on navigating a challenging macroeconomic environment for consumer staples, with debates focused on the company's ability to sustain growth and defend margins amid inflationary pressures and shifting consumer spending patterns, as evidenced by recent analyst rating adjustments reflecting a cautious but stabilizing outlook.…
BF-B
Brown-Forman Corporation
$26.17
Investment Opinion: Should I buy BF-B Today?
Rating: Hold. The core thesis is that Brown-Forman is a high-quality company with exceptional brands and margins caught in a low-growth phase, resulting in a fair valuation that offers limited near-term upside without a growth catalyst.
Supporting evidence includes a reasonable forward P/E of 15.60x, strong profitability (28.23% operating margin), and robust free cash flow generation ($730M TTM). However, these strengths are counterbalanced by anemic revenue growth (2.71% YoY), cautious analyst sentiment (Neutral consensus), and clear technical underperformance (-17.59% 1-year relative strength). The stock's 3.55% dividend yield provides some compensation for the wait.
The thesis would upgrade to a Buy if revenue growth accelerates sustainably above 5% YoY, if the forward P/E compresses below 14x, or if the stock breaks decisively above its 52-week high resistance of $31.92. It would downgrade to a Sell if quarterly revenue growth turns negative, if gross margins compress below 58%, or if the stock breaks below its 52-week low support of $22.61. Relative to its own history, the stock is fairly valued to slightly undervalued, but relative to its current growth profile, it appears fully valued.
Sign up to view all
BF-B 12-Month Price Forecast
Brown-Forman represents a classic 'quality at a fair price' scenario. The investment is a bet on stability, income (3.55% yield), and potential multiple expansion if growth re-emerges, rather than on explosive growth itself. The neutral stance reflects the offsetting forces of strong fundamentals against a weak growth and momentum backdrop. The stance would upgrade to bullish on evidence of sustained revenue acceleration above 5% or a further compression in the P/E multiple below 15x without deteriorating fundamentals. It would turn bearish if margins begin to contract or if the technical breakdown below $22.61 support occurs.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Brown-Forman Corporation's 12-month outlook, with a consensus price target around $34.02 and implied upside of +30.0% versus the current price.
Average Target
$34.02
13 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
13
covering this stock
Price Range
$21 - $34
Analyst target range
The stock is covered by 13 analysts, indicating substantial institutional interest. The consensus sentiment appears neutral, as evidenced by recent rating actions from major firms like Citigroup and JP Morgan moving to Neutral from more bearish stances, and Bernstein downgrading to Market Perform from Outperform. The average revenue estimate for the upcoming period is $4.82 billion, with a range from $4.71 billion to $4.92 billion, reflecting moderate growth expectations. While a specific consensus price target is not provided in the data, the pattern of institutional ratings and the lack of a strong bullish bias suggests the analyst community is taking a wait-and-see approach, likely aligning price targets close to the current trading range. The wide revenue estimate range signals some uncertainty around the near-term growth trajectory, which is typical for a company navigating a transitional period in its key markets.
Bulls vs Bears: BF-B Investment Factors
The evidence presents a balanced but leaning bearish picture for Brown-Forman. The bear case is currently stronger on momentum, with clear technical underperformance and cautious analyst sentiment overshadowing the company's fundamental strengths. The bull case is anchored in exceptional profitability, financial fortitude, and a historically attractive valuation. The single most important tension in the investment debate is whether the company's robust margins (60.87% gross) and iconic brands can sustainably offset its stagnating growth trajectory (2.71% YoY revenue growth). If growth re-accelerates, the valuation discount presents a major opportunity. If growth remains muted, the stock risks remaining in a value trap despite its quality characteristics.
Bullish
- Robust Profitability & Strong Margins: The company maintains exceptional pricing power and brand equity, evidenced by a gross margin of 60.87% and an operating margin of 28.23% in the latest quarter. This high-margin profile provides significant cushion against inflationary pressures and funds consistent shareholder returns.
- Strong Financial Health & Cash Generation: Brown-Forman boasts a fortress balance sheet with a low debt-to-equity ratio of 0.54 and a high current ratio of 3.24. Most importantly, it generates substantial free cash flow ($730M TTM), enabling reliable dividends (3.55% yield), share buybacks, and strategic investments without financial strain.
- Attractive Valuation Relative to History: The stock trades at a trailing P/E of 16.81x and a forward P/E of 15.60x, which is near the lower end of its own historical valuation range (which has seen peaks above 70x). This historical discount suggests a potential value opportunity if the company's fundamentals stabilize.
- Defensive Profile with Low Volatility: With a beta of 0.354, the stock is approximately 65% less volatile than the broader market. This defensive characteristic makes it a potential portfolio stabilizer during market downturns, as evidenced by its recent 3-month outperformance (+2.72% relative to SPY) amid market uncertainty.
Bearish
- Stagnant Growth Trajectory: Revenue growth is anemic, with the latest quarterly year-over-year increase of only 2.71%. This modest growth, coupled with a 1-year price return of +7.4% that severely underperformed the SPY (+24.99%), raises questions about the company's ability to re-accelerate and justify a premium valuation.
- Analyst Sentiment is Cautious & Neutral: Recent analyst actions from Citigroup, JP Morgan, and Bernstein have moved to Neutral or Market Perform ratings, reflecting a 'wait-and-see' stance. This lack of bullish conviction, from 13 covering analysts, suggests the Street sees limited near-term catalysts for a significant re-rating.
- Technical Downtrend & Underperformance: The stock is in a clear long-term downtrend, trading 17% below its 52-week high of $31.92. Despite a recent 3-month rally (+17.86%), the 1-year underperformance versus the market (-17.59% relative strength) indicates persistent selling pressure and a lack of sustained bullish momentum.
- High Short Interest Signals Skepticism: A short ratio of 4.55 indicates a significant level of bearish bets against the stock. This elevated short interest reflects market skepticism about the company's near-term prospects and adds potential selling pressure, which could cap upside moves.
BF-B Technical Analysis
The stock is in a pronounced downtrend over the past year, with a 1-year price change of only +7.40%, significantly underperforming the SPY's +24.99% gain. Currently trading at $26.64, the price sits approximately 17% above its 52-week low of $22.61 but remains 17% below its 52-week high of $31.92, positioning it in the lower-middle portion of its annual range, suggesting it is not yet at deep value levels but has experienced substantial weakness. Recent momentum shows a notable divergence, with a strong 3-month return of +17.86% and a 1-month gain of +3.67%, indicating a potential recovery attempt or bear market rally within the context of the longer-term underperformance. This short-term strength is further evidenced by the stock's relative strength versus the market, posting a +2.72% 3-month relative performance against the SPY. Key technical levels are clearly defined, with major resistance at the 52-week high of $31.92 and immediate support at the 52-week low of $22.61. A breakout above resistance would signal a reversal of the primary downtrend, while a breakdown below support could trigger a new leg lower. The stock's beta of 0.354 indicates it is approximately 65% less volatile than the broader market, which is typical for a defensive consumer staples name but also suggests muted potential for explosive upside moves.
Beta
0.34
0.34x market volatility
Max Drawdown
-51.9%
Largest decline past year
52-Week Range
$23-$32
Price range past year
Annual Return
-7.0%
Cumulative gain past year
| Period | BF-B Return | S&P 500 |
|---|---|---|
| 1m | -1.4% | +4.1% |
| 3m | -10.5% | +11.1% |
| 6m | +2.6% | +8.8% |
| 1y | -7.0% | +20.6% |
| ytd | +1.9% | +10.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BF-B Fundamental Analysis
Revenue growth is modest but positive, with the latest quarterly revenue of $1.063 billion representing a 2.71% year-over-year increase. Segment data reveals the Whiskey category, led by Jack Daniel's, is the primary growth engine, contributing $797 million, while Ready-to-Drink products added $146 million, indicating the company is successfully capitalizing on evolving consumption trends. Profitability remains robust, with the company reporting net income of $267 million and a healthy gross margin of 60.87% for the quarter. The net margin stands at 18.20%, and operating margin is 28.23%, reflecting strong pricing power and brand equity, though investors monitor these for potential compression from cost inflation. The balance sheet and cash flow position are solid, with a debt-to-equity ratio of 0.54 indicating moderate leverage, a strong current ratio of 3.24 signaling ample liquidity, and an ROE of 17.79% demonstrating efficient use of equity. Most importantly, the company generates substantial cash, with trailing twelve-month free cash flow of $730 million, providing flexibility for dividends, share buybacks (evident in recent cash flow statements), and organic investment without reliance on excessive external financing.
Quarterly Revenue
$1.1B
2026-01
Revenue YoY Growth
+2.71%
YoY Comparison
Gross Margin
60.87%
Latest Quarter
Free Cash Flow
$730000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BF-B Overvalued?
Given the company's consistent profitability, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is 16.81x, while the forward PE is 15.60x; the lower forward multiple suggests the market anticipates modest earnings growth. Compared to sector averages implied by its own historical data, the current trailing PE of 16.81x is below the stock's own multi-year historical range, which has seen peaks above 70x and sustained periods in the 20s and 30s. This historical context places the current valuation near the lower end of its own long-term spectrum, potentially indicating a value opportunity if fundamentals stabilize, or pricing in concerns over growth stagnation. The stock trades at a Price-to-Sales ratio of 3.06x and an EV/EBITDA of 12.50x, which are reasonable for a stable, branded consumer staples business with its margin profile, but the discount to its own history is the more salient comparison point.
PE
16.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 12x~80x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are moderate. The primary risk is growth stagnation, as the company's modest 2.71% YoY revenue increase may struggle to support its current valuation multiples (P/E 16.81x, P/S 3.06x) if it persists. While the balance sheet is strong (D/E 0.54), the company's heavy reliance on the Jack Daniel's brand creates concentration risk. Any sustained margin compression from inflation, which could pressure the current 60.87% gross margin, would directly impact earnings and free cash flow generation.
Market & Competitive Risks are elevated. The stock trades at a significant discount to its own historical valuation, but this discount may persist or widen if the market continues to penalize low-growth consumer staples. Competitive intensity in the premium spirits and RTD categories is high, threatening market share. The stock's low beta (0.354) offers downside protection but also limits explosive upside, making it vulnerable to sector rotation out of defensive names if the economic outlook improves. Recent analyst downgrades to Neutral reflect these growing concerns.
Worst-Case Scenario involves a combination of sustained growth deceleration, margin erosion from inflation, and a multiple compression cycle. This could trigger analyst downgrades and force the stock to re-test its 52-week low of $22.61. Given the stock's historical max drawdown of -51.89%, a severe but plausible downside from the current price of $26.64 would be a decline of approximately -15% to the 52-week low. A more extreme scenario, involving a fundamental deterioration of the Jack Daniel's brand, could see losses approach -30% or more, though this is less likely given the brand's entrenched position.
FAQ
The key risks are, in order of severity: 1) Growth Stagnation Risk: Persistent low-single-digit revenue growth could lead to further multiple compression. 2) Margin Compression Risk: Inflation could erode the company's high gross margin (60.87%), directly impacting profits. 3) Competitive & Market Share Risk: Intense competition in spirits and RTDs could pressure the flagship Jack Daniel's brand. 4) Sentiment & Technical Risk: The stock is in a technical downtrend and carries high short interest (ratio 4.55), which can fuel downward momentum on any negative news.
Our 12-month forecast outlines three scenarios. The Base Case (60% probability) sees the stock trading between $26 and $29, as low growth and neutral analyst sentiment persist. The Bull Case (25% probability) targets $30 to $32, driven by revenue re-acceleration and multiple expansion. The Bear Case (15% probability) warns of a drop to $22-$24 if margins compress and growth stalls further. The most likely outcome is the Base Case, predicated on the assumption that the company's strong fundamentals prevent a major decline, but lack of growth catalysts limits significant upside.
BF-B is fairly valued relative to its current fundamentals but appears undervalued relative to its own long-term history. The trailing P/E of 16.81x and forward P/E of 15.60x are reasonable for a company with its margin profile (28.23% operating margin) but low growth (2.71% revenue increase). Historically, the stock has traded at much higher multiples (often in the 20s and 30s), suggesting a discount. The market is currently paying a fair price for stability and cash flow, but not assigning a premium for growth, which the company is not currently demonstrating.
BF-B is a good buy for a specific type of investor: those seeking a defensive, lower-volatility holding with a reliable 3.55% dividend yield from a company with a pristine balance sheet. However, it is not a good buy for investors seeking high growth or short-term trading gains. The stock's 1-year underperformance (-17.59% vs. SPY) and low beta (0.354) highlight its defensive, slow-moving nature. The current valuation (P/E 16.81x) is fair, offering limited near-term upside without a growth catalyst, making it more of a 'Hold' than a compelling 'Buy' for most portfolios.
BF-B is unequivocally suitable for long-term investment, not short-term trading. Its low beta (0.354) and dividend focus make it a poor candidate for short-term volatility plays. The investment thesis is based on the enduring value of its brand portfolio and reliable cash generation over years, not quarterly catalysts. A long-term horizon (3-5 years minimum) allows investors to collect the dividend and potentially benefit from any eventual cyclical recovery in growth or valuation. Short-term traders would be better served by more volatile, catalyst-driven stocks.